EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

MASH: the nexus of metabolism, inflammation, and fibrosis

Gregory R Steinberg, Andre C Carpentier, Dongdong Wang

Journal of Clinical Investigation · 16.09.2025 · 135 (18)

DOI: 10.1172/jci186420 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Investigation, online erschienen am 16.09.2025. Verfasst von Gregory R Steinberg und 2 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Metabolism, Obesity and Diabetes Research, Division of Endocrinology and Metabolism, Department of Medicine, Faculty of Health Sciences, M…. Hauptthemen laut MEDLINE: Liver Cirrhosis, Hepatic Stellate Cells, Lipid Metabolism, Fatty Liver. Die Arbeit wurde bisher 144-mal zitiert (Crossref) und nennt 200 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic dysfunction–associated steatohepatitis (MASH) is a progressive form of liver disease characterized by hepatocyte injury, inflammation, and fibrosis. The transition from metabolic dysfunction–associated steatotic liver disease (MASLD) to MASH is driven by the accumulation of toxic lipid and metabolic intermediates resulting from increased hepatic uptake of fatty acids, elevated de novo lipogenesis, and impaired mitochondrial oxidation. These changes promote hepatocyte stress and cell death, activate macrophages, and induce a fibrogenic phenotype in hepatic stellate cells (HSCs). Key metabolites, including saturated fatty acids, free cholesterol, ceramides, lactate, and succinate, act as paracrine signals that reinforce inflammatory and fibrotic responses across multiple liver cell types. Crosstalk between hepatocytes, macrophages, and HSCs, along with spatial shifts in mitochondrial activity, creates a feed-forward cycle of immune activation and tissue remodeling. Systemic inputs, such as insulin-resistant adipose tissue and impaired clearance of dietary lipids and branched-chain amino acids, further contribute to liver injury. Together, these pathways establish a metabolically driven network linking nutrient excess to chronic liver inflammation and fibrosis. This Review outlines how coordinated disruptions in lipid metabolism and intercellular signaling drive MASH pathogenesis and provides a framework for understanding disease progression across tissue and cellular compartments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver CirrhosisHepatic Stellate CellsLipid MetabolismFatty LiverHumansInflammationAnimalsHepatocytesMacrophagesNon-alcoholic Fatty Liver DiseaseLiverSignal Transduction

Autor:innen und Institutionen

  • Centre for Metabolism, Obesity and Diabetes Research, Division of Endocrinology and Metabolism, Department of Medicine, Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada.
  • Centre de recherche du Centre hospitalier universitaire de Sherbrooke, Department of Medicine, Université de Sherbrooke, Sherbrooke, Quebec, Canada.

Zitieren

APA

Steinberg, G. R., Carpentier, A. C., & Wang, D. (2025). MASH: the nexus of metabolism, inflammation, and fibrosis. Journal of Clinical Investigation, 135(18). https://doi.org/10.1172/jci186420

Vancouver

Steinberg GR, Carpentier AC, Wang D. MASH: the nexus of metabolism, inflammation, and fibrosis. Journal of Clinical Investigation. 2025;135(18). doi:10.1172/jci186420

BibTeX
@article{Steinberg2025,
  author = {Steinberg, Gregory R and Carpentier, Andre C and Wang, Dongdong},
  title = {MASH: the nexus of metabolism, inflammation, and fibrosis},
  journal = {Journal of Clinical Investigation},
  year = {2025},
  volume = {135},
  number = {18},
  doi = {10.1172/jci186420}
}
Kostenlos starten →